Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Characteristics of HHT120 in Healthy Subjects

Summary

This is a first in human clinical trial with HHT120. The purpose of this study is to characterize the safety, pharmacokinetic (PK) and Pharmacodynamic (PD) profile of single and multiple twice-daily doses of HHT120 in healthy Subjects and to assess the effects of food on the PK profile of single-dose of HHT120 in healthy Subjects.

Timeline

Start

2022-07-01

Primary completion

2023-02-15

Completion

2023-03-01

Outcome

Outcome not reported

Stopped: “Commercialization consideration. Without safety issues.”

Drugs

Indications

No indication recorded.